Phase 3 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women who reached menopause between 2 and 6 years ago
- Women whose Body Mass Index (a measure of body weight relative to height) falls between 25 and 30
- Women who have had their uterus and ovaries surgically removed due to cervical cancer
- Women whose ovaries stopped working before the age of 40 (known as premature ovarian failure), and who are under 40 years old
- Women who are currently sexually active
- Women who do not have severe depression or severe anxiety, as confirmed by two standard questionnaires used in the screening process
Who may not be able to join:
- People living with serious illnesses that significantly limit daily functioning
- People currently taking medications that are known to reduce sexual desire
- People who are unable to complete written questionnaires
- People with severely high blood pressure (above 160/90 mmHg on two separate measurements)
- People with thyroid problems, confirmed by a specific hormone blood test result above a set level
- People with very high fasting triglyceride levels (a type of fat in the blood) above 400 mg/dL
- People with blood detected in their stool samples
- People with abnormally high levels of a hormone called prolactin in their blood
- People with fasting blood sugar levels above 100 mg/dL
- People diagnosed with reduced bone density or bone loss (osteopenia or osteoporosis)
- People whose mammogram (breast imaging) result falls into a category of concern (BIRADS 3 or higher)
- People whose internal uterine lining appears thicker than 4mm on an internal ultrasound scan
- People with abnormal results on a cervical cell screening test
- People found to have moderate to severe anxiety or depression following a psychological screening assessment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Edmund Baracat, PhD, Instituto do Coracao
Phone: 55 11 981348231
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluate hormonal, metabolic thromboembolic and clinical effects on climacteric symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.